Toronto, Ontario--(Newsfile Corp. - August 10, 2022) - Khiron Life Sciences Corp. (TSXV: KHRN) (OTCQX: KHRNF) (FSE: A2JMZC) ("Khiron" or the "Company"), a global leader in medical cannabis throughout Europe and Latin America, today announced that Alvaro Torres, CEO and Director of the Company will be attending the Q3 Virtual Investor Summit.
Q3 Investor Summit
August 16 & 17th, 2022
August 17 @ 9:30am ET
1x1s will be available for qualified investors.
The conference is completely complementary to qualified investors. Please register at
Complimentary Investor Registration
About Khiron Life Sciences:
Khiron is a leading vertically integrated international medical cannabis corporation with core operations in Latin America and Europe. Leveraging medical health clinics and proprietary telemedicine platforms, Khiron combines a patient-oriented approach, physician education programs, scientific, product innovation, and cannabis operations expertise to drive prescriptions and brand loyalty with patients worldwide. The Company has a sales presence in Colombia, Peru, Germany, United Kingdom, and Brazil and is positioned to commence sales in Mexico. The Company is led by co-founder and Chief Executive Officer, Alvaro Torres, together with an experienced and diverse executive team and Board of Directors.
Visit Khiron online at https://investors.khiron.ca.
+1 (647) 556-5750
Khiron Latin America
About Investor Summit Group
The Investor Summit (formerly MicroCap Conference) is an exclusive, independent conference dedicated to connecting smallcap and microcap companies with qualified investors. The Q3 Investor Summit will take place virtually, featuring 90+ companies and over 500 investors comprising institutional investors, family offices, and high net worth investors. Sectors Participating: Biotech, Communication Services, Consumer, Energy, Energy/Tech, Financial, Healthcare, Industrials, Materials, Real Estate, Technology, and Tech/Crypt. Contact: firstname.lastname@example.org
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/132874